Prevalence and lifetime risk of endoscopy-related complications among patients with inflammatory bowel disease

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 10, 2013, Pages 1288-1293

  Ferreira, Jason ^a   Akbari, Mona ^a   Gashin, Laurie ^a   Cullen, Garret ^a   Moss, Alan ^a   Leffler, Daniel A ^a   Aronson, Mark ^a   Cheifetz, Adam S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Colitis; Crohn's Disease; Endoscopy Safety; Mathematic Model

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLONOSCOPY; COLONOSCOPY RELATED COMPLICATION; COMPLICATION; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; EMERGENCY WARD; ENTERITIS; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROENTEROLOGIST; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; ISRAEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONTE CARLO METHOD; PATIENT SAFETY; POPULATION; PREVALENCE; RETROSPECTIVE STUDY; RISK; SIGMOIDOSCOPY;

BETH ISRAEL DEACONESS MEDICAL CENTER; BIDMC; CI; COLITIS; CONFIDENCE INTERVAL; CROHN'S DISEASE; ED; EGD; EMERGENCY DEPARTMENT; ENDOSCOPY SAFETY; ESOPHAGOGASTRODUODENOSCOPY; IBD; INFLAMMATORY BOWEL DISEASE; MATHEMATIC MODEL; UC; ULCERATIVE COLITIS;

COHORT STUDIES; COLONOSCOPY; FEMALE; HUMANS; IATROGENIC DISEASE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84884356405     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.04.047     Document Type: Article

References (11)

1. Seeff L.C., Richards T.B., Shapiro J.A., et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 2004, 127:1670-1677.
2. Rabeneck L., Paszat L.F., Hilsden R.J., et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008, 135:1899-1906.
3. de Jonge V., Sint Nicolaas J., van Baalen O., et al. The incidence of 30-day adverse events after colonoscopy among patients in the Netherlands. Am J Gastroenterol 2012, 107:878-884.
4. Navaneethan U., Kochhar G., Phull H., et al. Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory disease patients. JCrohns Colitis 2012, 6:470-475.
5. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130:1030-1038.
6. Terheggen G., Lanyi B., Schanz S., et al. Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy 2008, 40:656-663.
7. Leffler D.A., Kheraj R., Garud S., et al. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy. Arch Intern Med 2010, 170:1752-1757.
8. Heitman S.J., Ronksley P.E., Hilsden R.J., et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009, 7:1272-1278.
9. Leffler D.A., Kheraj R., Bhansali A., et al. Adenoma detection rates vary minimally with time of day and case rank: a prospective study of 2139 first screening colonoscopies. Gastrointest Endosc 2012, 75:554-560.
10. Arias E., Curtin L.R., Wei R., et al. U.S. Decennial Life Tablesfor 1999-2001, United States Life Tables. Natl Vital Stat Rep 2008, 57:1-40.
11. Itzkowitz S.H., Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321.